Potential role of miR-100 in cancer diagnosis, prognosis, and therapy (Q38367693)

2 September 2017

1 reference

title

Potential role of miR-100 in cancer diagnosis, prognosis, and therapy (English)

1 reference

2 September 2017

1 reference

Chu Qin

1

1 reference

2 September 2017

Ru-Yi Huang

series ordinal

2

1 reference

2 September 2017

Zhao-Xia Wang

series ordinal

3

1 reference

2 September 2017

publication date

5 March 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

36

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

1403-1409

1 reference

MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Genetic variation in microRNA networks: the implications for cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Evolution of the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNAs and the advent of vertebrate morphological complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

The miR-99 family regulates the DNA damage response through its target SNF2H

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Analysis of circulating microRNAs in adrenocortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Prognostic role of microRNA-100 in various carcinomas: evidence from six studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Genetics of lung-cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-3267-8

Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.

21 January 2018

1 reference

12 December 2020

microRNA regulation of the expression of the estrogen receptor in endometrial cancer

1 reference

12 December 2020

MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.

1 reference

12 December 2020

MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells

1 reference

12 December 2020

Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia

1 reference

12 December 2020

MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas

1 reference

12 December 2020

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer

1 reference

12 December 2020

Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.

1 reference

12 December 2020

10.1007/S13277-015-3267-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1030107727

0 references

1 reference